136 related articles for article (PubMed ID: 8974087)
21. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
22. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
[TBL] [Abstract][Full Text] [Related]
23. Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
Masumiya H; Tanaka H; Shigenobu K
Eur J Pharmacol; 1997 Sep; 335(1):15-21. PubMed ID: 9371541
[TBL] [Abstract][Full Text] [Related]
24. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
Schipke JD; Burkhoff D; Alexander J; Schaefer J; Sagawa K
J Pharmacol Exp Ther; 1988 Mar; 244(3):1000-4. PubMed ID: 3252017
[TBL] [Abstract][Full Text] [Related]
25. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats.
Fujiwara K; Kanno Y; Hayashi K; Takenaka T; Saruta T
Clin Exp Hypertens; 1998 Apr; 20(3):295-312. PubMed ID: 9605384
[TBL] [Abstract][Full Text] [Related]
26. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
[TBL] [Abstract][Full Text] [Related]
27. Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs.
Kenny D; Hartman JC; Brooks HL; Warltier DC
Pharmacology; 1989; 38(4):263-71. PubMed ID: 2755966
[TBL] [Abstract][Full Text] [Related]
28. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
29. Effects of efonidipine hydrochloride (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats.
Yotsumoto T; Masuda Y; Shudo C; Sugita H; Yamashita T; Tanaka S
Gen Pharmacol; 1995 Mar; 26(2):333-7. PubMed ID: 7590083
[TBL] [Abstract][Full Text] [Related]
30. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
31. Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
Lei B; Hitomi H; Mori T; Nagai Y; Deguchi K; Mori H; Masaki T; Nakano D; Kobori H; Kitaura Y; Nishiyama A
J Pharmacol Sci; 2011; 117(2):98-105. PubMed ID: 21897055
[TBL] [Abstract][Full Text] [Related]
32. Effect of nisoldipine upon the general and coronary hemodynamics of the anesthetized dog.
Maxwell GM; Crompton S; Rencis V
J Cardiovasc Pharmacol; 1982; 4(3):393-7. PubMed ID: 6177935
[TBL] [Abstract][Full Text] [Related]
33. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
Ehring T; Heusch G
Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Uchida W; Shibasaki K; Asano M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of a new dihydropyridine calcium antagonist.
Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
Jolly SR; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
[TBL] [Abstract][Full Text] [Related]
39. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
Ikeda K; Saito T; Tojo K
Tohoku J Exp Med; 2011 Aug; 224(4):263-71. PubMed ID: 21757861
[TBL] [Abstract][Full Text] [Related]
40. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
